Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins

Virology

Volumn 222, Issue 1, 1996, Pages 87-99

  Omar, Abdul R ^a   Schat, Karel A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL LINE; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPETOVIRUS; MARDIVIRUS; RETICULOENDOTHELIOSIS VIRUS;

EID: 0030219062     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0400     Document Type: Article

References (58)

1. Anderson, A. S., Francesoni, A., and Morgan, R. W. (1992). Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology 189, 657-667.
2. Bacon, L. D., and Witter, R. L. (1993). Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Dis. 37, 53-59.
3. Banks, T. A., Allen, E. M., Dasjupta, S., Sandri-Goldin, R., and Rouse, B. T. (1991). Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27. J. Virol. 65, 3185-3191.
4. Binns, M. M., and Ross, N. L. J. (1989). Nucleotide sequence of the Marek's disease virus (MDV) RB1B A antigen and the identification of the MDVA antigen as the herpes simplex virus-2 glycoprotein C homologue. Virus Res. 12, 371-382.
5. b-restricted, HSV-1, and HSV-2 cross-reactive cytotoxic T lymphocytes clones. Virology 195, 62-70.
6. Brunovskis, P., and Velicer, L. F. (1995). The Marek's disease virus (MDV) unique short region: Alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206, 324-338.
7. Buckmaster, A. E., Scott, S. D., Sanderson, M. J., Bournsnell, M. E. G., Ross, L. J. N., and Binns, M. M. (1988). Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys-implications for herpesvirus classification. J. Gen. Virol. 69, 2033-2042.
8. Calnek, B. W., Carlisle, J. C., Fabricant, J., Murthy, K. K., and Schat, K. A. (1979). Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am. J. Vet. Res. 40, 541-548.
9. Calnek, B. W. (1985). Genetic resistance. In "Marek's Disease: Scientific Basis and Methods of Control" (L. N. Payne, Ed.), pp. 293-327. Nijhoff, Boston, MA.
10. Cantin, E. M., Eberle, R., Baldick, J. L., Moss, B., Willey, D. E., Notkins, A. L., and Openshaw, H. (1987). Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA 84, 5908-5912.
11. Chen, X., Sondermeijer, P. J. A., and Velicer, L. F. (1992). Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66, 85-94.
12. Churchill, A. E., and Biggs, P. M. (1967). Agent of Marek's disease in tissue culture. Nature 215, 528-530.
13. Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76, 287-299.
14. Ghiasi, H., Kaiwar, R., Nesburn, A. B., Slanina, S., and Wechsler, S. L. (1994). Expression of seven herpes simplex virus type 1 glycoprotein (gB, gC, gD, gE, gG, gH and gI): Comparative protection against lethal challenge in mice. J. Virol. 68, 2118-2126.
15. Hanke, T., Graham, F. L., Rosenthal, K. L., and Johnson, D. C. (1991). Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65, 1177-1186.
16. Hong, Y., and Coussens, P. M. (1994). Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide. J. Virol. 68, 3593-3603.
17. Hrdlickova, R., Nehyba, J., and Humpries, E. H. (1994). v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel. J. Virol. 68, 308-319.
18. Jones, D., Lee, L. F., Liu, J. L., Kung, H-J., and Tillotson, J. K. (1992). Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. USA 89, 4042-4046.
19. Lillehoj, H. S., Lillehoj, E. P., Weinstock, D., and Schat, K. A. (1988). Functional and biochemical characterizations of avian T lymphocyte antigens identified by monoclonal antibodies. Eur. J. Immunol. 18, 2059-2065.
20. Maccubbin, D. B., and Schierman, L. W. (1986). MHC-restricted cytotoxic response of chicken T cells: expression, augmentation, and clonal characterization. J. Immunol. 136, 12-16.
21. Martin, S., Zhu, X., Silverstein, S. J., Courtney, R. J., Yao, F., Jenkins, F. J., and Rouse, B. T. (1990). Murine cytotoxic T lymphocytes specific for herpes simplex type 1 recognize the immediate early protein ICP4 but not ICP0. J. Gen. Virol. 71, 2391-2399.
22. Nazerian, K., Lee, L. F., Yanagida, N., and Ogawa, R. (1992). Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66, 1409-1413.
23. Ohashi, K., Zhou, W., O'Connell, P. H., and Schat, K. A. (1994a). Characterization of a Marek's disease virus BamHI-L-specific cDNA clone obtained from a Marek's disease lymphoblastoid cell line. J. Virol. 68, 1191-1195.
24. Ohashi, K., O'Connell, P. H., and Schat, K. A. (1994b). Characterization of Marek's disease virus BamHI-A-specific cDNA clones obtained from a Marek's disease lymphoblastoid cell line. Virology 199, 275-283.
25. Okazaki, W., Purhase, H. G., and Burmester, B. R. (1970). Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14, 413-429.
26. Omar, A. R., Schat, K. A., and Lee, L. F., unpublished data.
27. Ono, M., Kawaguchi, Y., Maeda, K., Kamiya, N., Tohya, Y., Kai, C., Niikura, M., and Mikami, T. (1994). Nucleotide sequence analysis of Marek's disease virus (MDV) serotype 2 homology of MDV serotype 1 pp38, an antigen associated with transformed cells. Virology 201, 142-146.
28. Ono, M., Kawaguchi, Y., Jang, H. K., Tohya, Y., Niikura, M., and Mikami, T. (1995). Expression of Marek's disease virus (MDV) serotype 2 gene which has partial homology with MDV serotype 1 pp38 gene. Virus Res. 35, 223-229.
29. Peng, F., Bardely, G., Tanaka, A., Lancz, G., and Nonoyama, M. (1992). Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus. J. Virol. 66, 7389-7396.
30. Powell, P. C. (1985). Immunity. In "Marek's Disease: Scientific Basis and Methods of Control" (L. N. Payne, Ed.), pp. 177-202. Nijhoff, Boston, MA.
31. Powell, P. C., Mustil, B. M., and Rennie, M. (1983). The role of histocompatibility antigens in cell-mediated cytotoxicity against Marek's disease tumor-derived lymphoblastoid cell lines. Avian Pathol. 12, 461-468.
32. Pratt, W. D., Morgan, R., and Schat, K. A. (1992). Cell-mediated cytolysis of lymphoblastoid cells expressing Marek's disease virus-specific phosphorylated polypeptides. Vet. Microbiol. 33, 93-99.
33. Ren, D., Lee, L. F., and Coussens, P. M. (1994). Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1. Virology 204, 242-250.
34. Ross, L. J. N., Sanderson, M., Scott, S. D., Binns, M. M., Doel, T., and Milne, B. (1989). Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 70, 1789-1804.
35. Sakaguchi, M., Urakawa, T., Hirayama, Y., Miki, N., Yamamoto, M., and Hirai, K. (1992). Sequence determination and genetic content of an 8.9-kb restriction fragment in the short unique region and the internal inverted repeat of Marek's disease virus type 1 DNA. Virus Genes 6, 365-378.
36. Sambrook, J., Fritch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," 2nd ed., Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
37. Schat, K. A. (1987). Marek's disease: A model for protection against herpesvirus-induced tumours. Cancer Sur. 6, 1-37.
38. Schat, K. A., and Calnek, B. W. (1978). Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60, 1073-1082.
39. Schat, K. A., and Calnek, B. W. (1980). In vitro cytotoxicity of spleen lymphocytes against Marek's disease tumor cells: induction by SB-1, an apparently nononcogenic Marek's disease virus. In "Resistance and Immunity to Marek's Disease" (P. M. Biggs, Ed.), pp. 301-319. EEC Publication, Luxembourg.
40. Schat, K. A., Calnek, B. W., and Fabricant, J. (1982a). Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11, 593-605.
41. Schat, K. A., and Heller, E. D. (1985). A chromium-release assay for the study of cell mediated immune responses to Marek's disease antigens. In "Proceedings of the International Symposium on Marek's Disease" (B. W. Calnek and J. L. Spencer, Eds.), pp. 301-316. Am. Assoc. Avian Pathol., Kennett Square, PA.
42. Schat, K. A., Pratt, W. D., Morgan, R., Weinstock, D., and Calnek, B. W. (1992). Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36, 432-439.
43. Schat, K. A., Shek, W. R., Calnek, B. W., and Abplanalp, H. (1982b). Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines. Int. J. Cancer. 29, 187-194.
44. Scott, S. D., Smith, G. D., Ross, N. L. J., and Binns, M. M. (1993). Identification and sequence analysis of the homologues of the herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkeys. J. Gen. Virol. 74, 1185-1190.
45. Sharma, J. M., Witter, R. L., and Coulson, B. D. (1977). Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines. J. Natl. Cancer. Inst. 61, 1273-1280.
46. Smith, G. D., Zelnik, V., and Ross, L. J. N. (1995). Gene organization in herpesvirus of turkeys: Identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 207, 205-216.
47. Snedecor, J. L., and Cochran, W. G. (1971). "Statistical Methods," 6th ed. Iowa State Univ. Press, Ames.
48. Thacker, E. L., Fulton, J. E., and Hunt, H. D. (1995). In vitro analysis of a primary, major histocompatibility complex (MHC)-restricted, cytotoxic T lymphocyte response to avian leukosis virus (ALV) using target cells expressing MHC class I cDNA inserted into a recombinant ALV, vector. J. Virol. 69, 6439-6444.
49. Uni, Z., Pratt, W. D., Miller, M. M., O'Connell, P. H., and Schat, K. A. (1994). Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells. Vet. Immunopathol. 44, 57-69.
50. Weinstock, D., Schat, K. A., and Calnek, B. W. (1989). Cytotoxic T lymphocytes in reticuloendotheliosis virus-infected chickens. Eur. J. Immunol. 19, 267-272.
51. Weinstock, D., and Schat, K. A. (1987). Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. In "Avian Immunology" (W. T. Weber and D. L. Ewert, Eds.), pp. 253-263. A. R. Liss, NY.
52. Witmer, L. A., Rosenthal, K. L., Graham, F. L., Friedman, H. M., Yee, A., and Johnson, D. C. (1990). Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins. J. Gen. Virol. 71, 387-396.
53. Witter, R. L., Kato, S., Calnek, B. W., and Powell, P. C. (1979). A proposed method for designating avian cell lines and transplantable tumors. Avian Pathol. 8, 487-498.
54. Witter, R. L., Sharma, J. M., Lee, L. F., H. Optiz, H. M., and Henry, C. W. (1984). Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28, 44-60.
55. Yanagida, N., Ogawa, R., Lee, L. F., and Nazerian, K. (1992). Recombinant fowlpox viruses expressing the glycoprotein B homology and the pp38 gene of Marek's disease virus. J. Virol. 66, 1402-1408.
56. Yoshida, S., Lee, L. F., Yanagida, N., and Nazerian, K. (1994). Identification and characterization of a Marek's disease virus gene homologous to glycoprotein L of herpes simplex virus. Virology 204, 414-419.
57. Zelnik, V. (1995). Marek's disease and new approaches to its control. Acta Virologica 39, 53-63.
58. Zivny, J., Kurane, I., Leporati, A. M., Ibe, M., Takiguchi, M., Zeng, L. L., Brinton, M. A., and Ennis, F. A. (1995). A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogenous serotype specificities. J. Exp. Med. 182, 853-863.